[The role of bemitil pharmacokinetics in realizing its therapeutic efficacy].
The pharmacokinetics of a new psychotropic drug bemithil was studied after single and long-term administrations under monotherapy and in combination with phenazepam in patients with asthenoneurotic disturbances. A high degree of correlation for some pharmacokinetic parameters of bemithil following the administration of the drug test dose and its global therapeutic effect was established.
S S
SS
Boĭko
V P
VP
Zherdev
G G
GG
Neznamov
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001247:Asthenia / Q000097:blood / Q000188:drug therapy; D001562:Benzimidazoles / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000097:blood / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013997:Time Factors
D014151:Anti-Anxiety Agents; D001562:Benzimidazoles; D001570:Benzodiazepinones; D011619:Psychotropic Drugs; D001569:Benzodiazepines; C017928:phenazepam; C049825:bemethyl
Rol' farmakokinetiki bemitila v realizatsii ego terapevticheskoĭ éffektivnosti.